Epidemiology of diabetic retinopathy and maculopathy in Africa: A systematic review

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages 399-412

  Burgess, Philip I ^a,b   MacCormick, I J C ^a,b   Harding, S P ^b   Bastawrous, A ^c   Beare, N A V ^d   Garner, P ^e  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION; CLINICAL PRACTICE; DIABETIC MACULOPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; HUMAN; INCIDENCE; INCOME; PATIENT SELECTION; PREVALENCE; PRIMARY MEDICAL CARE; PROLIFERATIVE DIABETIC RETINOPATHY; RETINA MACULOPATHY; REVIEW; SYSTEMATIC REVIEW; AFRICA; EPIDEMIOLOGY; HOSPITALIZATION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA EDEMA; STATISTICS; VISUAL ACUITY;

AFRICA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EPIDEMIOLOGIC METHODS; HOSPITALIZATION; HUMANS; MACULAR EDEMA; VISUAL ACUITY;

EID: 84879686052     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03756.x     Document Type: Review

References (81)

1. IDF. Diabetes Atlas. 4th edition. Brussels: International Diabetes Federation, 2009.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4–14.
3. United Nations Statistics Division. Composition of Macro Geographical (Continental) Regions. Available at http://unstats.un.org/unsd/methods/m49/m49regin.htm#least Last accessed 1 April 2011.
4. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthal 1985; 103: 1796–1806.
5. Hamilton AMP, Ulbig MW, Polkinghorne P. Management of Diabetic Retinopathy. London: BMJ Publishing Group, 1996.
6. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Statement and Checklist. Available at http://www.prisma-statement.org/Lasts accessed 1 April 2011.
7. Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998; 147: 448–457.
8. 1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997; 20: 785–791.
9. Abdull MM, Sivasubramaniam S, Murthy GV, Gilbert C, Abubakar T, Ezelum C et al.; Nigeria National Blindness and Visual Impairment Study Group. Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. Invest Ophthalmol Vis Sci 2009; 50: 4114–4120.
10. Tapp RJ, Zimmet PZ, Harper CA, McCarty DJ, Chitson P, Tonkin AM et al. Six-year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract 2006; 73: 298–303.
11. Gill GV, Huddle KR, Krige LP. Intensive health screening of young black diabetics. S Afr Med J 1984; 65: 815–816.
12. Gill GV, Huddle KR, Rolfe M. Mortality and outcome of insulin-dependent diabetes in Soweto, South-Africa. Diabet Med 1995; 12: 546–550.
13. Gill GV, Huddle KRL, Monkoe G. Long-term (20 years) outcome and mortality of Type 1 diabetic patients in Soweto, South Africa. Diabet Med 2005; 22: 1642–1646.
14. Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y et al. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethn Dis 2003; 13: S110–S117.
15. Sidibe AT, Dembele M, Cisse A, Alwata F, Ahmedou Ould MY, Coulibaly T et al. Diabetic hand infections in hospital practice in Bamako, Mali. Diabetes Metab 2006; 32: 89.
16. Sullivan FM, Rosalie D, Sivakumar U. Using insulin U 100 conversion to estimate the prevalence and problems of insulin-treated diabetic patients in the Republic of Seychelles. Diabetologia 1990; 33: 184–185.
17. Taylor RH, Jones HS, Dodson PM, Hamilton AP, Kritzinger EE. Diabetic eye disease: a natural history study. Eye 1997; 11: 547–553.
18. Gill GV, Gebrekidan A, English P, Wile D, Tesfaye S. Diabetic complications and glycaemic control in remote North Africa. QJ Med 2008; 101: 793–798.
19. Rotchford AP, Rotchford KM. Diabetes in rural South Africa—an assessment of care and complications. S Afr Med J 2002; 92: 536– 541.
20. Elmahdi EM, Kaballo AM, Mukhtar EA. Features of non-insulin-dependent diabetes mellitus (NIDDM) in the Sudan. Diabetes Res Clin Pract 1991; 11: 59–63.
21. Majaliwa ES, Munubhi E, Ramaiya K, Mpembeni R, Sanyiwa A, Mohn A et al. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care 2007; 30: 2187–2192.
22. El-Shazly M, Zaki A, Nicolucci A. Care-related risk factors for chronic diabetic complications in developing countries: a case from Egypt. Public Health 2002; 116: 289–296.
23. Ashaye AO, Adeoti CO. Neovascular glaucoma in a Nigerian African population. East Afr Med J 2006; 83: 559–564.
24. Oluleye TS, Ajaiyeoba AI. Retinal diseases in Ibadan. Eye 2006; 20: 1461–1463.
25. Teshome T, Melaku S. Pattern of retinal diseases at a teaching eye department, Addis Ababa, Ethiopia. Ethiop Med J 2004; 42: 185– 193.
26. Poole TRG. Causes of blindness in Northern Tanzania: a hospital and rural health centre based study. Int Ophthalmol 2001; 24: 195–198.
27. Carreras FJ, Rodriguez-Hurtado F, David H. Ophthalmology in Luanda (Angola): a hospital based report. Br J Ophthalmol 1995; 79: 926–933.
28. Eze BI, Uche JN, Shiweobi JO. The burden and spectrum of vitreo-retinal diseases among ophthalmic outpatients in a resource-deficient tertiary eye care setting in South-eastern Nigeria. Middle East Afr J Ophthalmol 2010; 17: 246–249.
29. Nwosu SNN. Prevalence and pattern of retinal diseases at the Guinness Eye Hospital, Onitsha, Nigeria. Ophthalmic Epidemiol 2000; 7: 41–48.
30. Onakpoya OH, Olateju SO, Ajayi IA. Retinal diseases in a tertiary hospital: the need for establishment of a vitreo-retinal care unit. J Natl Med Assoc 2008; 100: 1286–1289.
31. Carmichael TR, Carp GI, Welsh ND, Kalk WJ. Effective and accurate screening for diabetic retinopathy using a 60 degree mydriatic fundus camera. S Afr Med J 2005; 95: 57–61.
32. Distiller LA, Brown MA, Joffe BI, Kramer BD. Striving for the impossible dream: a community-based multi-practice collaborative model of diabetes management. Diabet Med 2010; 27: 197– 202.
33. Distiller LA, Joffe BI, Melville V, Welman T, Distiller GB. Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus. J Diabetes Complications 2006; 20: 280–284.
34. Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, Sous ES et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998; 15: 1045–1051.
35. Kalk WJ, Joannou J, Ntsepo S, Mahomed I, Mahanlal P, Becker PJ. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. J Intern Med 1997; 241: 31–37.
36. Mash B, Powell D, du Plessis F, van Vuuren U, Michalowska M, Levitt N. Screening for diabetic retinopathy in primary care with a mobile fundal camera—evaluation of a South African pilot project. S Afr Med J 2007; 97: 1284–1288.
37. Mollentze WF, Stulting AA, Steyn AF. Ophthalmoscopy versus non-mydriatic fundus photography in the detection of diabetic retinopathy in black patients. S Afr Med J 1990; 78: 248–250.
38. Harzallah F, Alberti H, Kanoun F, Elhouch F, Slimane H. Quality of care of patients with type 2 diabetes in a Tunisian university hospital. Diabetes Metab 2004; 30: 523–526.
39. Macky TA, Khater N, Al-Zamil MA, El Fishawy H, Soliman MM. Epidemiology of Diabetic Retinopathy in Egypt: a hospital-based study. Ophthalmic Res 2011; 45: 73–78.
40. Mwale C, Karimurio J, Njuguna M. Refractive errors in type 2 diabetic patients. East Afr Med J 2007; 84: 259–263.
41. Penman AD, Saaddine JB, Hegazy M, Sous ES, Ali MA, Brechner RJ et al. Screening for diabetic retinopathy: the utility of non-mydriatic retinal photography in Egyptian adults. Diabet Med 1998; 15: 783– 787.
42. Thompson TJ, Engelgau MM. The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabet Med 1996; 13: 337–340.
43. Lester FT. Clinical status of Ethiopian diabetic patients after 20 years of diabetes. Diabet Med 1991; 8: 272–276.
44. Alebiosu CO, Odusan O, Jaiyesimi A. Morbidity in relation to stage of diabetic nephropathy in type 2 diabetic patients. J Natl Med Assoc 2003; 95: 1042–1047.
45. Omolase CO, Adekanle O, Owoeye JF, Omolase BO. Diabetic retinopathy in a Nigerian community. Singapore Med J 2010; 51: 56–59.
46. Onakpoya OH, Adeoye AO, Kolawole BA. Determinants of previous dilated eye examination among type II diabetics in Southwestern Nigeria. Eur J Intern Med 2010; 21: 176–179.
47. Ikem RT, Akinola NO. What does the presence of hypertension portend in the Nigerian with non-insulin-dependent diabetes mellitus. West Afr J Med 2001; 20: 127–130.
48. Longo-Mbenza B, Nkondi Mbadi ANJ, Mbungu Fuele S. Higher pulse pressure, systolic arterial hypertension, duration of diabetes and family history of diabetes in Central Africans. Int J Diabetes Metab 2008; 16: 17–23.
49. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract 1999; 44: 191–196.
50. Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumolo S. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med 1997; 14: 1073– 1077.
51. Read O, Cook C. Retinopathy in diabetic patients evaluated at a primary care clinic in Cape Town. S Afr Med J 2007; 97: 941–944.
52. Glover SJ, Burgess PI, Cohen DB, Harding SP, Hofland HWC, Zijlstra EE et al. Prevalence of diabetic retinopathy, cataract and visual impairment in diabetic patients in Sub-Saharan Africa. Br J Ophthalmol 2012; 96: 156–161.
53. Elbagir MN, Eltom MA, Mahadi EO, Berne C. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract 1995; 30: 59–67.
54. Seyoum B, Mengistu Z. Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J 2001; 39: 123–131.
55. Mumba M, Hall A, Lewallen S. Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital. Ophthalmic Epidemiol 2007; 14: 306–310.
56. Lester FT. Clinical features, complications and mortality in type 1 (insulin-dependent) diabetic patients in Addis Ababa, Ethiopia, 1976–1990. Q J Med 1992; 83: 389–399.
57. Lester FT. Clinical features, complications and mortality in type 2 (non-insulin dependent) diabetic patients in Addis Abeba, Ethiopia, 1976–1990. Ethiop Med J 1993; 31: 109–126.
58. Huddle KR. Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992–2002. J Endocrinol Metab Diabetes S Afr 2005; 10: 102–107.
59. Mengesha AY. Spectrum of eye disorders among diabetes mellitus patients in Gaborone, Botswana. Trop Doct 2006; 36: 109–111.
60. Joannou J, Kalk WJ, Mahomed I, Ntsepo S, Berzin M, Joffe BI et al. Screening for diabetic retinopathy in South Africa with 60 degrees retinal colour photography. J Intern Med 1996; 239: 43–47.
61. Levitt NS. Diabetes in Africa: epidemiology, management and health care challenges. Heart 2008; 4: 1376–1382.
62. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet 2010; 375: 2254–2266.
63. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009; 52: 8–16.
64. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS et al. Prevalence of diabetic retinopathy in the United States, 2005– 2008. J Am Med Assoc 2010; 304: 649–656.
65. Younis N, Broadbent DM, Harding SP, Vora JP. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 2002; 19: 1014–1021.
66. Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycaemic control. Acta Ophthalmol Scand 1996; 74: 523–527.
67. Kristinsson JK, Stefonsson E, Janasson F, Goslason I, Bjornsson S. Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol 1994; 72: 341–346.
68. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR et al. UK Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297–303.
69. Burnett S, Hurwitz B, Davey C, Ray J, Chaturvedi N, Salzmann J et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med 1998; 15: S38– S43.
70. Wong TY, Klein R, Islam A. Diabetic retinopathy in a multiethnic cohort in the United states. Am J Ophthalmol 2006; 141: 446–455.
71. Harris MJ, Klein R, Cowie CC. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? Diabetes Care 1998; 21: 1230–1235.
72. Chen Y, Huang H, Zhou J, Doumatey A, Lashley K, Chen G et al. Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis 2007; 13: 2142–2147.
73. ACCORD Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363: 233–244.
74. Stratton IM, Kohner EM, Aldington SJ. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156–163.
75. Klein R, Klein BE, Moss SE. The Wisconsin Epidemiological Study of Diabetic Retinopathy: a review. Diabetes Metab Rev 1989; 5: 559–570.
76. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520–526.
77. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527–532.
78. Resnikoff S, Pascolini D, Etya’ale D. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–51.
79. International Monetary Fund. World Economic Outlook Database. September 2011. Available at http://www.imf.org/external/data. htm Last accessed 4 October 2011.
80. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 1985; 28: 615–640.
81. Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999; 13: 160–165. Appendix S1. Search histories.